RxDoctor Payments Data

Brittany Adams, APRN

Psychiatric/Mental Health · Saint Joseph, MONPI 1689236218

Payments from drug & device makers

$751in general payments, 2019–2025

Across 44 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$403
  • Sunovion Pharmaceuticals Inc.$88
  • Alkermes, Inc.$58
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$44
  • Lundbeck LLC$43
  • Teva Pharmaceuticals USA, Inc.$37
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$751100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$751 in reported general payments places this provider in the 45th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$9,547
Medicare patients
32
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate102$341,304
VraylarCariprazine Hcl96$126,972
Abilify MaintenaAripiprazole40$108,703
RexultiBrexpiprazole38$55,604
AristadaAripiprazole Lauroxil17$45,619
VivitrolNaltrexone Microspheres18$31,515
Quetiapine Fumarate ErQuetiapine Fumarate54$30,724
Clomipramine Hcl14$17,983
TrintellixVortioxetine Hydrobromide33$14,078
AuvelityDextromethorphan Hbr/Bupropion11$12,634
Lurasidone Hcl19$6,897
Clozapine90$3,579
Atomoxetine Hcl24$3,059
Quetiapine Fumarate164$3,016
Olanzapine194$2,745

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$403$126,97296 claims
Alkermes, Inc.Aristada, Vivitrol$58$77,13435 claims
Axsome Therapeutics, Inc.Auvelity$15$12,63411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Saint Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →